COVID-19 Program

When the COVID-19 pandemic hit in March 2020, we listened to the challenges and concerns of our clients. In response, we launched a comprehensive solution to ensure that their workplaces were COVID-19 safe.

Safeguard your workforce while maintaining productivity.

Our COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan to limit the possibility of workplace COVID-19 transmission among workers. Our COVID-19 solution integrates with your existing health and safety protocols.

The COVID-19 solution integrates guidelines from both the CDC and OSHA into an overall workplace surveillance and response plan. Our team, led by pandemic response expert, Dr. William Lang, has created this program to keep your employees safe and healthy while ensuring maximum efficiency.

The Benefits of our COVID-19 Program

Lower risk of transmission among employees

Day-to-day operational stability

Reduced workforce downtime

Confident, more engaged workforce

Diminished COVID-related claims

Decreased risk of litigation

The Results

The positive impact of our pandemic safety program is clear.

%

of employees screened daily

managed potential exposures

man-days of work saved (so far!)

Scott Gerard, VP of Safety, Moss Construction

“Our partnership with JobSiteCare has been tremendously successful in keeping our team members healthy and our job sites open without interruption and no COVID-19 related claims.”

COVID-19 Blog & Updates

COVID-19 Infectivity, Vaccines, Treatment, and Epidemiology

COVID-19 Infectivity, Vaccines, Treatment, and Epidemiology

There was a large study announced this week from Australia addressing the survival of the virus on various surfaces. They found the virus could be recovered over a longer duration of time than previously thought, but also found that there was generally more rapid decay.

COVID-19 Vaccine Progress, Current Trends, and Quick Facts

COVID-19 Vaccine Progress, Current Trends, and Quick Facts

The biggest news this week is that both Dr. Stephen Hahn, Commissioner of the FDA, and Dr. Tony Fauci of the NIH both said that a limited Emergency Use Authorization for at least one of the vaccines could be issued as early as late October or early November.

Subscribe to Our Newsletter

Join our community and receive information and updates on workplace health and safety and the latest JobSiteCare news.

Contact us

Call Us

Our Location

Boston, New York, Washington D.C.

Get in touch